Italfarmaco and VeriSIM Life partner on novel therapeutics for rare diseases

Italfarmaco and VeriSIM Life announced a strategic collaboration to discover and develop novel HDAC-targeted therapeutic assets for neuromuscular, fibrotic, and rare diseases. The partnership has a potential value exceeding $100 million.